{"schema_version":"1","generated_at":"2026-11-15T04:23:52.616Z","data_as_of":null,"url":"https://www.findmykol.com/kol/james-brugarolas","json_url":"https://www.findmykol.com/kol/james-brugarolas/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"james-brugarolas","name":"James Brugarolas","credential":"MD, PhD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Dallas","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1629091723"},"summary":"James Brugarolas is an Oncology physician. ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04989959","title":"[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"Orhan Kemal Oz","source_url":"https://clinicaltrials.gov/study/NCT04989959","trial_url":"https://www.findmykol.com/trial/NCT04989959"},{"nct":"NCT04006522","title":"89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"James Brugarolas","source_url":"https://clinicaltrials.gov/study/NCT04006522","trial_url":"https://www.findmykol.com/trial/NCT04006522"}],"source":"trials"},"payments":{"company_count":8,"program_years":{"first":2021,"last":null},"rows_total":24,"shown":3,"withheld":21,"rows":[{"payer":"Merck & Co.","program_year":2025,"amount_usd":1041854.69,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1629091723"},{"payer":"Genentech","program_year":2025,"amount_usd":84330,"payment_count":17,"source_url":"https://openpaymentsdata.cms.gov/search?query=1629091723"},{"payer":"PFIZER INC.","program_year":2025,"amount_usd":149.17,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1629091723"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1629091723","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":2,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":66,"drugs":[{"name":"Inlyta","share_pct":67.7},{"name":"Cabometyx","share_pct":32.3}],"max_beneficiaries":null},{"class":"Hypoxia-inducible Factor Inhibitor","setting":"prescribed","share_pct":34,"drugs":[{"name":"Welireg","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":64.3,"facility_pct":35.7},"source":"medicare"},"funding":{"award_count":6,"fiscal_years":{"first":2006,"last":2026},"rows_total":57,"shown":3,"withheld":54,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"P50CA196516","title":"University of Texas Southwestern Medical Center SPORE in Kidney Cancer","fiscal_year":2026,"amount_usd":"2337000","organization":"UT SOUTHWESTERN MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/P50CA196516"},{"project":"R01CA289885","title":"Leveraging First Mouse Model Reproducing Human Translocation Renal Cell Carcinoma to Investigate Molecular Mechanisms","fiscal_year":2026,"amount_usd":"596501","organization":"UT SOUTHWESTERN MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/R01CA289885"},{"project":"P50CA196516","title":"Project 1: Targeting HIF2 in Renal Cell Carcinoma","fiscal_year":2026,"amount_usd":"357521","organization":"UT SOUTHWESTERN MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/P50CA196516"}],"source":"grants"},"contact":{"address_1":"5323 HARRY HINES BLVD","city":"Dallas","state":"TX","zip":"753907208","phone":"214-645-8600","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1629091723","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":21,"funding":54}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2008-03-31","collected_at":"2026-11-06T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}